Pfizer Canada gets Health Canada approval for Beqvez to treat haemophilia B
The approval was based on the open-label, single-arm Phase 3 BENEGENE-2 study in which a single dose of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Jan 24
The approval was based on the open-label, single-arm Phase 3 BENEGENE-2 study in which a single dose of…
04 Jan 24
The amendment also consists of an amicable resolution to their commercial dispute and several other adjustments to improve…
04 Jan 24
Only FDA-Approved As-Needed Treatment For The Approximately 6 Million Premenopausal Women Who Suffer From Hypoactive Sexual Desire Disorder
02 Jan 24
The late-stage multi-centre, randomised, double-masked, placebo-controlled trial will evaluate the safety and effectiveness of ST-100 ophthalmic solution in…
02 Jan 24
According to an interim analysis, healthy individuals aged 40 years and above showed an overall favourable safety and…
26 Dec 23
Karuna is a biopharmaceutical firm focused on the discovery, development and delivery of transformative medicines for individuals with…
22 Dec 23
The authorisation was based on the findings from the Phase 3 SOLSTICE trial in which Livtencity was found…
21 Dec 23
OCE-205 is a therapeutic peptide with a differentiated mechanism of action, designed to relieve portal hypertension while offering…
21 Dec 23
Palatin's focus is solely on its development and clinical pipeline based on the melanocortin receptor system
20 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions